1
Name
1 Name
(1) This instrument is the National Health (Prescriber Bag Supplies) Determination 2024. (2) This instrument may also be cited as PB 29 of 2024.
//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Commonwealth legislation
This Determination authorises certain medical practitioners, authorised nurse practitioners and authorised midwives to supply particular medicines from “prescriber bags” and sets monthly maximum unit limits and mutually exclusive groups for those supplies. The specific drugs, forms, authorised supplier types, maximum quantities and group numbers are listed in Schedule 1.
It matters because it determines who may lawfully obtain and supply those medicines each calendar month, creating compliance obligations for practitioners and preventing simultaneous access to multiple items within the same group.
Want the full deep dive?
Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.
Direct links to the current provisions in National Health (Prescriber Bag Supplies) Determination 2024.
(1) This instrument is the National Health (Prescriber Bag Supplies) Determination 2024. (2) This instrument may also be cited as PB 29 of 2024.
This instrument is made under sections 93, 93AA and 93AB of the National Health Act 1953.
Note 1: Under subsection 4(1A) of the Act, a word or phrase defined for the purposes of the Health Insurance Act 1973 has the meaning that it would have if used in that Act. Expressions used in this instrument that are defined in that Act include ‘medical practitioner’.
In this instrument:
Act means the National Health Act 1953.
authorised midwife has the same meaning as in Part VII of the Act.
authorised nurse practitioner has the same meaning as in Part VII of the Act.
pharmaceutical benefit has the same meaning as in Part VII of the Act.
pharmaceutical benefit has a drug has the same meaning as in Part VII of the Act.
pharmaceutical benefit that has a drug in a relevant form: see section 5.
A reference in this instrument to a pharmaceutical benefit that has a drug in a relevant form is a reference to a pharmaceutical benefit that has a drug mentioned in an item in Schedule 1 in the column headed “Listed Drug” in the form mentioned for that drug in the column in Schedule 1 headed “Form”.
(1) For the purposes of subsection 93(1) of the Act, a medical practitioner is authorised to supply a pharmaceutical benefit that has a drug in a relevant form if the initials “MP” are mentioned for that drug in that form in the column in Schedule 1 headed “Prescriber Bag Supplier”. (2) For the purposes of subsection 93AB(1) of the Act, an authorised nurse practitioner is authorised to supply a pharmaceutical benefit that has a drug in a relevant form if the initials “NP” are mentioned for that drug in that form in the column in Schedule 1 headed “Prescriber Bag Supplier”. (3) For the purposes of subsection 93AA(1) of the Act, an authorised midwife is authorised to supply a pharmaceutical benefit that has a drug in a relevant form if the initials “MW” are mentioned for that drug in that form in the column in Schedule 1 headed “Prescriber Bag Supplier”.
(1) This section determines the maximum number of units of a pharmaceutical benefit that has a drug in a relevant form which may be obtained by a medical practitioner, an authorised midwife or an authorised nurse practitioner (a practitioner) in a calendar month for the purposes of subsections 93(2), 93AA(2) and 93AB(2) of the Act. (2) The maximum number of units is the number of units mentioned in the column in Schedule 1 headed “Maximum Quantity” for that drug in that form. (3) Despite subsection (2), if a practitioner has already obtained 1 or more units of a pharmaceutical benefit that has a drug in a relevant form in a group in the same calendar month, the maximum number of units of any other pharmaceutical benefit that has a drug in a relevant form in that group is zero for that calendar month. (4) For this section, a group is each pharmaceutical benefit that has a drug in a relevant form which has the same number mentioned for the drug and form in the column in Schedule 1 headed “Group Number”.
Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.
(1) This instrument is the National Health (Prescriber Bag Supplies) Determination 2024. (2) This instrument may also be cited as PB 29 of 2024.
This instrument is made under sections 93, 93AA and 93AB of the National Health Act 1953.
Note 1: Under subsection 4(1A) of the Act, a word or phrase defined for the purposes of the Health Insurance Act 1973 has the meaning that it would have if used in that Act. Expressions used in this instrument that are defined in that Act include ‘medical practitioner’.
In this instrument:
Act means the National Health Act 1953.
authorised midwife has the same meaning as in Part VII of the Act.
authorised nurse practitioner has the same meaning as in Part VII of the Act.
pharmaceutical benefit has the same meaning as in Part VII of the Act.
pharmaceutical benefit has a drug has the same meaning as in Part VII of the Act.
pharmaceutical benefit that has a drug in a relevant form: see section 5.
A reference in this instrument to a pharmaceutical benefit that has a drug in a relevant form is a reference to a pharmaceutical benefit that has a drug mentioned in an item in Schedule 1 in the column headed “Listed Drug” in the form mentioned for that drug in the column in Schedule 1 headed “Form”.
(1) For the purposes of subsection 93(1) of the Act, a medical practitioner is authorised to supply a pharmaceutical benefit that has a drug in a relevant form if the initials “MP” are mentioned for that drug in that form in the column in Schedule 1 headed “Prescriber Bag Supplier”. (2) For the purposes of subsection 93AB(1) of the Act, an authorised nurse practitioner is authorised to supply a pharmaceutical benefit that has a drug in a relevant form if the initials “NP” are mentioned for that drug in that form in the column in Schedule 1 headed “Prescriber Bag Supplier”. (3) For the purposes of subsection 93AA(1) of the Act, an authorised midwife is authorised to supply a pharmaceutical benefit that has a drug in a relevant form if the initials “MW” are mentioned for that drug in that form in the column in Schedule 1 headed “Prescriber Bag Supplier”.
(1) This section determines the maximum number of units of a pharmaceutical benefit that has a drug in a relevant form which may be obtained by a medical practitioner, an authorised midwife or an authorised nurse practitioner (a practitioner) in a calendar month for the purposes of subsections 93(2), 93AA(2) and 93AB(2) of the Act. (2) The maximum number of units is the number of units mentioned in the column in Schedule 1 headed “Maximum Quantity” for that drug in that form. (3) Despite subsection (2), if a practitioner has already obtained 1 or more units of a pharmaceutical benefit that has a drug in a relevant form in a group in the same calendar month, the maximum number of units of any other pharmaceutical benefit that has a drug in a relevant form in that group is zero for that calendar month. (4) For this section, a group is each pharmaceutical benefit that has a drug in a relevant form which has the same number mentioned for the drug and form in the column in Schedule 1 headed “Group Number”.